Skip To Main Content
Larissa Tames Rainho on Muck Rack

Larissa Tames Rainho

As seen in: European Journal of Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Larissa Tames

Contact Larissa Tames, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: analysis of the NIVOREN GETUG-AFU 26 study

|
By Loïc Mourey, Gustave Roussy, IUCT-Oncopole Claudius Regaud, Larissa Tames Rainho
| European Journal of Cancer Verified
Immune checkpoint inhibitors are standard of care in metastatic renal cell carcinoma but their activity and safety in elderly patients is insufficiently explored. We evaluated outcomes of elderly patients with mRCC treated with nivolumab in the GETUG-AFU 26 NIVOREN phase 2 trial (NCT03013335) and conducted exploratory circulating biomarker analyses. Patients with mRCC were treated with nivolumab after at least one antiangiogenic therapy.
Open in Who Shared Issue with article?
See all 1 articles